The gut-liver axis model has often explained liver disease physiopathology. Among the latter we can mention Non-Alcoholic Liver Steatosis (NAFLD), Liver Steatohepatitis (NASH), liver cirrhosis. In this frame an altered Intestinal Permeability (IP) is the gate for antigenic/toxic substances from gut lumen until target organs such as liver in NAFLD. Altered intestinal permeability was discovered almost forty years ago as consequence of acute and chronic alcohol ingestion. Alcohol Liver Disease (ALD) is a systemic pathology whose beginning and end belong to the intestine. Several recent evidences from the literature show how gut microbiota composition can be altered by alcohol, affects IP and can be modulated by several nonpharmacological and pharmacological agents, becoming the target for ALD treatment. In this review we describe the definition of ALD, gut microbiota composition in healthy and ALD, definition and role of IP in ALD physiopathology and emerging evidences on gut microbiota modulation in ALD treatment from preliminary clinical and non-clinical studies.

Gut Microbiota and Alcoholic Liver Disease / Scarpellini, Emidio; Forlino, Mariana; Lupo, Marinella; Rasetti, Carlo; Fava, Giammarco; Abenavoli, Ludovico; DE SANTIS, Adriano. - In: REVIEWS ON RECENT CLINICAL TRIALS. - ISSN 1574-8871. - STAMPA. - 11:3(2016), pp. 213-219.

Gut Microbiota and Alcoholic Liver Disease

SCARPELLINI, EMIDIO;DE SANTIS, Adriano
2016

Abstract

The gut-liver axis model has often explained liver disease physiopathology. Among the latter we can mention Non-Alcoholic Liver Steatosis (NAFLD), Liver Steatohepatitis (NASH), liver cirrhosis. In this frame an altered Intestinal Permeability (IP) is the gate for antigenic/toxic substances from gut lumen until target organs such as liver in NAFLD. Altered intestinal permeability was discovered almost forty years ago as consequence of acute and chronic alcohol ingestion. Alcohol Liver Disease (ALD) is a systemic pathology whose beginning and end belong to the intestine. Several recent evidences from the literature show how gut microbiota composition can be altered by alcohol, affects IP and can be modulated by several nonpharmacological and pharmacological agents, becoming the target for ALD treatment. In this review we describe the definition of ALD, gut microbiota composition in healthy and ALD, definition and role of IP in ALD physiopathology and emerging evidences on gut microbiota modulation in ALD treatment from preliminary clinical and non-clinical studies.
2016
01 Pubblicazione su rivista::01a Articolo in rivista
Gut Microbiota and Alcoholic Liver Disease / Scarpellini, Emidio; Forlino, Mariana; Lupo, Marinella; Rasetti, Carlo; Fava, Giammarco; Abenavoli, Ludovico; DE SANTIS, Adriano. - In: REVIEWS ON RECENT CLINICAL TRIALS. - ISSN 1574-8871. - STAMPA. - 11:3(2016), pp. 213-219.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/930076
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 22
social impact